Skip to main content
. Author manuscript; available in PMC: 2023 Dec 1.
Published in final edited form as: Econ Hum Biol. 2022 Nov 21;47:101201. doi: 10.1016/j.ehb.2022.101201

Table A1.

Regressions for All-Cause Excess Mortality per Capita

(1) (2) (3) (4)
Estimation method SUR SUR Instruments Instruments
Period I: 3/20/21–6/12/21
 vaccination rate −.0024 (.0018) −.0012 (.0021) .0012 (.0125) .0012 (.0125)
Period II: 6/12/21–9/4/21
 vaccination rate −.0082*** (.0019) −.0078*** (.0020) −.0057* (.0031) −.0057* (.0031)
Period III: 9/4/21–12/4/21
 vaccination rate −.0089*** (.0018) −.0094*** (.0018) −.0052* (.0031) −.0062* (.0032)
 vaccination rate, older -- -.0052 (.0039) -- -.0005 (.0041)
 joint p-value 0.000 0.012
 p-value for equal coeffs 0.29 0.027
Period IV: 12/4/21–2/26/22
 vaccination rate −.0002 (.0023) .0001 (.0026) .0026 (.0030) .0023 (.0034)
 vaccination rate, older -- −.0006 (.0032) -- .0031 (.0038)
 joint p-value 0.98 0.68
 p-value for equal coeffs 0.84 0.82
R-squared .36 .60 .60 .36 .36 .60 .61 .36 .37 .59 .59 .34 .37 .59 .56 .34
s.e. .0004 .0007 .0008 .0009 .0004 .0007 .0008 .0009 .0004 .0007 .0008 .0009 .0004 .0007 .0009 .0009

Note: The specification is the same as in Table 2 except that the death rate is measured by all-cause excess mortality per capita and Period V is excluded.